Skip to main content
. 2020 Mar 11;12(5):4337–4347. doi: 10.18632/aging.102883

Table 4. Blood parameters and vascularisation; prostate size ≥ 70 mL.

Group A ≥ 70 mL (placebo) Group B ≥ 70 mL (dutasteride) p value
Hemoglobin before HoLEP, (g/dl) ± SD 14.14 ± 2.02 14.21 ± 2.31 0.48
Hemoglobin after HoLEP, (g/dl) ± SD 12.40 ± 1.99 12.52 ± 2.11 0.49
ΔHb ±SD 1.74 ± 0.22 1.69 ± 0.17
Hematocrit before HoLEP, % ± SD 43.02 ± 3.89 42.59 ± 3.43 0.64
Hematocrit after HoLEP, % ± SD 40.19 ± 4.00 40.25 ± 3.77 0.77
ΔHt ±SD 2.83 ± 0.54 2.34 ± 0.49
MVD 26.83 ± 2.12 20.76 ± 0.79 < .05
VEGF index 8.54 ± 1.18 3.21 ± 0.54 < .05

HoLEP: Holmium Laser Enucleation of the Prostate; MVD: microvascular density; VEGF index: vascular endothelial growth factor index; SD: standard deviation.